StandardStandard

Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. / Hughes, D.; Hughes, D.A.
2007. Papur a gyflwynwyd yn 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.

Allbwn ymchwil: Cyfraniad at gynhadleddPapur

HarvardHarvard

Hughes, D & Hughes, DA 2007, 'Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire', Papur a gyflwynwyd yn 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA, 3/01/02.

APA

Hughes, D., & Hughes, D. A. (2007). Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. Papur a gyflwynwyd yn 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.

CBE

Hughes D, Hughes DA. 2007. Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. Papur a gyflwynwyd yn 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.

MLA

Hughes, D. a D.A. Hughes Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA, 03 Ion 0002, Papur, 2007.

VancouverVancouver

Hughes D, Hughes DA. Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. 2007. Papur a gyflwynwyd yn 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.

Author

Hughes, D. ; Hughes, D.A. / Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. Papur a gyflwynwyd yn 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.

RIS

TY - CONF

T1 - Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire

AU - Hughes, D.

AU - Hughes, D.A.

PY - 2007/5/1

Y1 - 2007/5/1

M3 - Paper

T2 - 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA

Y2 - 3 January 0002

ER -